Onc AI Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 17

Onc AI General Information

Description

Developer of a deep learning imaging platform designed to improve oncology decision-making through enhanced analysis of diagnostic scans. The company's platform offers radiomic-based AI models integrated with real-world clinical data and a cloud-based analytics interface, enabling oncologists and pharmaceutical researchers to optimize treatment planning and trial outcomes with predictions of patient response and survival.

Contact Information

Website
www.onc.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bay Area
  • San Francisco, CA
  • United States
+1 (650)
Primary Industry
Decision/Risk Analysis
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • Bay Area
  • San Francisco, CA
  • United States
+1 (650)

Onc AI Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Onc AI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Generating Revenue
3. Grant 24-Oct-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Jan-2023 $25M $31M Completed Generating Revenue
1. Seed Round 02-Dec-2020 $6M $6M Completed Generating Revenue
To view Onc AI’s complete valuation and funding history, request access »

Onc AI Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Onc AI’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Onc AI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a deep learning imaging platform designed to improve oncology decision-making through enhanced analysis of
Decision/Risk Analysis
San Francisco, CA
27 As of 2026

Boston, MA
 

Chesterfield, MO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Onc AI Competitors (41)

One of Onc AI’s 41 competitors is GenoSpace, a Corporate Backed or Acquired company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GenoSpace Corporate Backed or Acquired Boston, MA
Partek Corporate Backed or Acquired Chesterfield, MO
PierianDx Private Equity-Backed Creve Coeur, MO
DNAnexus Venture Capital-Backed San Francisco, CA
CureMetrix Venture Capital-Backed San Diego, CA
You’re viewing 5 of 41 competitors. Get the full list »

Onc AI Patents

Onc AI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260134512-A1 Reducing the impact of varying ct convolution kernels on machine learning algorithms Pending 14-Nov-2024
WO-2026107263-A1 Reducing the impact of varying ct convolution kernels on machine learning algorithms Pending 14-Nov-2024
US-20260080995-A1 Predictive modeling of therapeutic agent response based on a body composition anatomical segmentation of a ct scan Pending 13-Sep-2024
WO-2026059794-A1 Predictive modeling of therapeutic agent response based on a body composition anatomical segmentation of a ct scan Pending 13-Sep-2024
US-20250349000-A1 Automated segmentation of a ct scan for predictive modeling of therapeutic agent response using deep learning analysis Pending 07-May-2024 G16H20/00
To view Onc AI’s complete patent history, request access »

Onc AI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Onc AI Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
515 Ventures Venture Capital Minority
Action Potential Venture Capital Corporate Venture Capital Minority
Life Extension Ventures Venture Capital Minority
Massachusetts Mutual Life Insurance Corporation Minority
You’re viewing 5 of 17 investors. Get the full list »

Onc AI FAQs

  • When was Onc AI founded?

    Onc AI was founded in 2020.

  • Where is Onc AI headquartered?

    Onc AI is headquartered in San Francisco, CA.

  • What is the size of Onc AI?

    Onc AI has 27 total employees.

  • What industry is Onc AI in?

    Onc AI’s primary industry is Decision/Risk Analysis.

  • Is Onc AI a private or public company?

    Onc AI is a Private company.

  • What is Onc AI’s current revenue?

    The current revenue for Onc AI is .

  • How much funding has Onc AI raised over time?

    Onc AI has raised $31M.

  • Who are Onc AI’s investors?

    National Cancer Institute, 515 Ventures, Action Potential Venture Capital, Life Extension Ventures, and Massachusetts Mutual Life Insurance are 5 of 17 investors who have invested in Onc AI.

  • Who are Onc AI’s competitors?

    GenoSpace, Partek, PierianDx, DNAnexus, and CureMetrix are some of the 41 competitors of Onc AI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process